title: High molecular weight corticotropin measured with immunoradiometric assay in a patient with asymptomatic pituitary corticotropinoma.
abstract: A 57-yr-old female with corticotropinoma showing no Cushingoid stigmata is reported. Basal plasma levels of ACTH measured with immunoradiometric assay and beta-endorphin were high, 12.6-15.9 pmol/l and 3.5 pmol/l, respectively. Plasma cortisol level and urinary free cortisol excretion were normal, 303-359 nmol/l and 171-226 nmol/day, respectively. Plasma ACTH markedly increased to 70.5 pmol/l with intravenous administration of 100 microg CRH. Diurnal rhythm of plasma ACTH was seen, but its level in the night was still high. Plasma ACTH suppression with dexamethasone was insufficient. CRH stimulation after dexamethasone suppression increased plasma ACTH level from 4.4 to 13.7 pmol/l. Intravenous administration of 4 microg desmopressin increased plasma ACTH from 15.6 to 19.6 pmol/l. Oral administration of 16 mg lepramide insufficiently decreased plasma ACTH from 7.3 to 5.3 pmol/l. However, plasma cortisol responses in these conditions were normal. Postoperative pathological study revealed subtype 1 corticotropinoma immunohistochemically and electron-microscopically. Postoperative basal plasma ACTH decreased to 3.9 pmol/l, although plasma cortisol did not change. Diurnal rhythm and dexamethasone suppressibility of plasma ACTH became normal. Plasma sample was chromatographed on a Sephadex G-75 column. The elution profile showed two peaks of ACTH, one of which was compatible with 1-39 ACTH and another with higher molecular weight ACTH which was probably secreted from corticotropinoma. Anomaly in processing of proopiomelanocortin was suspected.
authors.affiliation: Department of Internal Medicine, Matsunami General Hospital, Kasamatsu, Gifu, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Yamakita
authors.forename: T
authors.initials: T
authors.lastname: Murai
authors.forename: S
authors.initials: S
authors.lastname: Kawamura
authors.forename: H
authors.initials: H
authors.lastname: Teramachi
authors.forename: T
authors.initials: T
authors.lastname: Matsuhisa
authors.forename: T
authors.initials: T
authors.lastname: Hirata
authors.forename: T
authors.initials: T
authors.lastname: Ikeda
authors.forename: H
authors.initials: H
authors.lastname: Morita
authors.forename: T
authors.initials: T
authors.lastname: Mune
authors.forename: K
authors.initials: K
authors.lastname: Yasuda
mesh_terms: D000236:Adenoma / Q000097:blood* / Q000473:pathology / Q000652:urine; D000324:Adrenocorticotropic Hormone / Q000097:blood* / Q000737:chemistry; D002940:Circadian Rhythm; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000652:urine; D008875:Middle Aged; D008970:Molecular Weight; D009363:Neoplasm Proteins / Q000097:blood* / Q000737:chemistry / Q000652:urine; D010911:Pituitary Neoplasms / Q000097:blood* / Q000473:pathology / Q000652:urine
chemical_list: D009363:Neoplasm Proteins; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone